Fabric
  • Login
  • Register
    • Login
    • Register
  • 4981 Objects
  • About
  • Browse
      • Objects
      • Analytics
  • Analytics
  • Research
  • Contact
  • Decimal

19 Object Results
Filter results
  • Add all results to lightbox
  • Select results to add to lightbox
  • Sort by:
  • Date
  • Title
  • Sort order:
  • Ascending
  • Descending
  • Download results as:
  • Checklist
  • PDF (thumbnails)
  • Excel (basic information)
  • PowerPoint (basic information)

Search: "Digital Pills"
Brain-Computer Startup Aims to Treat Depression Without Opening a Skull

Brain-Computer Startup Aims to Treat Depression Without Opening a Skull

Otsuka America Pharmaceutical, Inc., Purchases the Assets of Proteus Digital Health, Inc.

Otsuka America Pharmaceutical, Inc., Purchases the Assets of Proteus Digital Health, Inc.

Ingestible sensors, data, and pharmaceuticals: Subjectivity in the era of digital mental health

Ingestible sensors, data, and pharmaceuticals: Subjectivity in the era of digital mental health

Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects

Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects

etectRx's ingestible adherence tracker system cleared by FDA

etectRx's ingestible adherence tracker system cleared by FDA


The Promise and Pitfalls of Digital Medication

Final Proteus Letter to the Federal Communications Commission

Final Proteus Letter to the Federal Communications Commission

Abilify MyCite Patient Terms of Use and Privacy Notice

Abilify MyCite Patient Terms of Use and Privacy Notice

Otsuka and Proteus® Announce the First U.S. FDA Approval of a Digital Medicine System: Abilify MyCite® (aripiprazole tablets with sensor)

Otsuka and Proteus® Announce the First U.S. FDA Approval of a Digital Medicine System: Abilify MyCite® (aripiprazole tablets with sensor)

Abilify MyCite® Overview

Abilify MyCite® Overview

FDA Approval Letter Abilify MyCite (aripiprazole)

FDA Approval Letter Abilify MyCite (aripiprazole)

First Digital Pill Approved to Worries About Biomedical ‘Big Brother’

First Digital Pill Approved to Worries About Biomedical ‘Big Brother’


UMMS researchers use digital pill to study medication adherence


Researchers use digital pill to study medication adherence


The frightening promise of self-tracking pills

US regulators accept ‘chip in a pill’ application

US regulators accept ‘chip in a pill’ application

Proteus Digital Health - Your Health, Powered By You

Proteus Digital Health - Your Health, Powered By You

Eric Topol on exciting new technologies

Eric Topol on exciting new technologies

Evaluation of Automatic Class III Designation (De Novo) for Proteus Personal Monitor Including Ingestion Event Marker

Evaluation of Automatic Class III Designation (De Novo) for Proteus Personal Monitor Including Ingestion Event Marker

Next 36

Filter by

HCI Platform
Implantable
Ingestible
Relation to body
In
Discursive Type
A Response to an Invention
An Invention
Persuasive Type
Academic
Advertisement
Information
Media Type
Loading...
collection
Policy and Privacy Implications of Ingestibles (2020-2021)
Related Body Part
Abdomen
Arm
Brain
Digestive tract
Entire body
Hand
Head
Neck
Skin
Throat
and 3 more
Augments
Adhering
Communicating
Controlling
Diagnosing
Feeling
Healing
Managing
Monitoring
Regulating
Remembering
Sensing
Surveilling
Swallowing
Testing
Thinking
Tracking
Treating
Understanding
and 11 more
People/Companies/Related Entities
Adam Hanina
Ameet Sarpatwari
Andrea Martani
Andrew Thompson
Andrew Ward
Andrew Wright
Arthur Caplan
Beth Walsh
BioMed Central
Bloomberg L.P.
Brigham and Women's Hospital
Bryan Goodchild
Christopher Poppe
Clinical Innovation And Technology
Columbia University
Dave Muoio
Edward Boyer
Eric Buffkin
Eric Topol
EtectRx
Federal Communications Commission (FCC)
Financial Times
Food and Drug Administration (FDA)
Harvard Medical School
Inner Cosmos Inc.
Jacinthe Flore
Jeffrey Lieberman
Jobson Medical Information LLC
Lester Darryl Geneviève
Marlene H. Dortch
Meron Gribetz
Meta Company
MobiHealthNews
New York University (NYU)
Olga Hilas
Otsuka Pharmaceutical
Pam Belluck
Paul Appellate
Proteus Digital Health
Royal Melbourne Institute of Technology (RMIT University)
Russell Brandom
Sage Journals
Sarah McBride
Sarah Willey
Scripps Translational Science Institute
The Center for Drug Evaluation and Research
The New York Times Company
Tina Caliendo
UMass Med
University Of Massachusetts
University Of Pittsburgh Medical Center UPMC
Vox Media Inc.
William Shrank
and 46 more
Technology
Activity Trackers
Biometrics
Biosensors
Brain Implants
Brain Stimulation
Brain-Computer Interface (BCI)
Chip in a pill
Data
Database
Digital Health
Digital Medicine
Digital Pills
Fitness Trackers
Health Tracker
Ingestible Adherence Tracking System
Ingestible Capsules
Ingestible Electronic Devices
Ingestible Event Marker (IEM) Sensor
Ingestible Sensors
Intra-body Communication
Lie Detector
Magnets
Medical Device
Medicine Tracking
Microchips
Mobile Applications
Monitoring Device
Notifications
Patch
Remote Monitoring
Remote Patient Monitoring
Sensor Data
Sensors
Smart Pills
Smartphone Applications
Software
Tele-Medicine
Wearable sensors
Web Portal
Wireless Connectivity
and 33 more
Marketing
Abilify MyCite
AiCure
Big Brother
Bluetooth
CINAHL
Embase
EtectRx
ID-Cap System
Inner Cosmos
Meta
Neuralink Corp.
Otsuka Pharmaceutical
Paradromics
Proteus Digital Health
Proteus Personal Monitor
Scopus (MEDLINE)
Synchron
and 10 more
Keyword
Behaviour
Big Pharma
Brain Function
Business Closure
Cognitive Enhancement
Communication
Compliance
Consent
Control
Controversy
Depression
Doctors
Elderly
Emotional enhancement
Emotions
Ethics
Funding
Government
Health
Innovation
Law
Medical
Medication
Mental Health
Mood
Patients
Pharmaceuticals
Policy
Pre-Release
Privacy
Regulation
Research
Schizophrenia
Sleep
Stomach Acid
Subjectivity
Surveillance
Terms of Service
and 31 more
title
Abilify MyCite Patient Terms of Use and Privacy Notice
Abilify MyCite® Overview
Brain-Computer Startup Aims to Treat Depression Without Opening a Skull
Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects
Eric Topol on exciting new technologies
EtectRx's ingestible adherence tracker system cleared by FDA
Evaluation of Automatic Class III Designation (De Novo) for Proteus Personal Monitor Including Ingestion Event Marker
FDA Approval Letter Abilify MyCite (aripiprazole)
Final Proteus Letter to the Federal Communications Commission
First Digital Pill Approved to Worries About Biomedical ‘Big Brother’
Ingestible sensors, data, and pharmaceuticals: Subjectivity in the era of digital mental health
Otsuka America Pharmaceutical, Inc., Purchases the Assets of Proteus Digital Health, Inc.
Otsuka and Proteus® Announce the First U.S. FDA Approval of a Digital Medicine System: Abilify MyCite® (aripiprazole tablets with sensor)
Proteus Digital Health - Your Health, Powered By You
Researchers use digital pill to study medication adherence
The Promise and Pitfalls of Digital Medication
The frightening promise of self-tracking pills
UMMS researchers use digital pill to study medication adherence
US regulators accept ‘chip in a pill’ application
and 12 more
Publication Title
BMC Medical Ethics
Bloomberg
Clinical Innovation and Technology
Food and Drug Administration (FDA)
MobiHealthNews
New Media & Society
Otsuka Pharmaceutical
Proteus Digital Health
The Financial Times Limited
The New York Times
The Verge
U.S. Pharmacist
UMass Med
UMass Medical School
and 7 more
© 2023 Decimal Lab
powered by CollectiveAccess 2023